Literature DB >> 25263479

Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.

Robert D Gibbons1, Marcelo Coca Perraillon, Kwan Hur, Rena M Conti, Robert J Valuck, David A Brent.   

Abstract

PURPOSE: In the 2004, FDA placed a black box warning on antidepressants for risk of suicidal thoughts and behavior in children and adolescents. The purpose of this paper is to examine the risk of suicide attempt and self-inflicted injury in depressed children ages 5-17 treated with antidepressants in two large observational datasets taking account time-varying confounding.
METHODS: We analyzed two large US medical claims databases (MarketScan and LifeLink) containing 221,028 youth (ages 5-17) with new episodes of depression, with and without antidepressant treatment during the period of 2004-2009. Subjects were followed for up to 180 days. Marginal structural models were used to adjust for time-dependent confounding.
RESULTS: For both datasets, significantly increased risk of suicide attempts and self-inflicted injury were seen during antidepressant treatment episodes in the unadjusted and simple covariate adjusted analyses. Marginal structural models revealed that the majority of the association is produced by dynamic confounding in the treatment selection process; estimated odds ratios were close to 1.0 consistent with the unadjusted and simple covariate adjusted association being a product of chance alone.
CONCLUSIONS: Our analysis suggests antidepressant treatment selection is a product of both static and dynamic patient characteristics. Lack of adjustment for treatment selection based on dynamic patient characteristics can lead to the appearance of an association between antidepressant treatment and suicide attempts and self-inflicted injury among youths in unadjusted and simple covariate adjusted analyses. Marginal structural models can be used to adjust for static and dynamic treatment selection processes such as that likely encountered in observational studies of associations between antidepressant treatment selection, suicide and related behaviors in youth.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  antidepressants; children and adolescents; marginal structural models; pharmacoepidemiology; self-inflicted injury; suicide attempts; time-varying confounding

Mesh:

Substances:

Year:  2014        PMID: 25263479      PMCID: PMC4312179          DOI: 10.1002/pds.3713

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  22 in total

1.  Waiting for organ transplantation: results of an analysis by an Institute of Medicine Committee.

Authors:  Robert D Gibbons; Naihua Duan; David Meltzer; Andrew Pope; Edward D Penhoet; Nancy N Dubler; Charles Francis; Barbara Gill; Eva Guinan; Maureen Henderson; Suzanne T Ildstad; Patricia A King; Manuel Martinez-Maldonado; George E McLain; Joseph Murray; Dorothy Nelkin; Mitchell W Spellman; Sarah Pitluck
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

2.  Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.

Authors:  Robert D Gibbons; C Hendricks Brown; Kwan Hur; John Davis; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2012-06

Review 3.  Pharmacogenomics of suicidal events.

Authors:  David Brent; Nadine Melhem; Gustavo Turecki
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

4.  Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarction.

Authors:  Joseph A C Delaney; Stella S Daskalopoulou; Samy Suissa
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-01       Impact factor: 2.890

5.  Impulsive-aggressive behaviours and completed suicide across the life cycle: a predisposition for younger age of suicide.

Authors:  A McGirr; J Renaud; A Bureau; M Seguin; A Lesage; G Turecki
Journal:  Psychol Med       Date:  2007-09-06       Impact factor: 7.723

6.  Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.

Authors:  Mark Olfson; Steven C Marcus; David Shaffer
Journal:  Arch Gen Psychiatry       Date:  2006-08

7.  Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.

Authors:  Nancy R Cook; Stephen R Cole; Charles H Hennekens
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

8.  Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

Authors:  David A Brent; Graham J Emslie; Greg N Clarke; Joan Asarnow; Anthony Spirito; Louise Ritz; Benedetto Vitiello; Satish Iyengar; Boris Birmaher; Neal D Ryan; Jamie Zelazny; Matthew Onorato; Betsy Kennard; Taryn L Mayes; Lynn L Debar; James T McCracken; Michael Strober; Robert Suddath; Henrietta Leonard; Giovanna Porta; Martin B Keller
Journal:  Am J Psychiatry       Date:  2009-02-17       Impact factor: 18.112

9.  An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease.

Authors:  Sengwee Toh; Joann E Manson
Journal:  Stat Biosci       Date:  2013-11-01

10.  Suicide attempts among patients starting depression treatment with medications or psychotherapy.

Authors:  Gregory E Simon; James Savarino
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

View more
  7 in total

1.  Chronic exposure to fluoxetine of female mice before mating causes impaired stress resilience in female offspring.

Authors:  Chenghao Yang; Jijian Si; Lin Suo; Yan Zhang; Jie Li
Journal:  J Neural Transm (Vienna)       Date:  2019-09-04       Impact factor: 3.575

Review 2.  Dosing and Monitoring: Children and Adolescents.

Authors:  Glenn S Hirsch
Journal:  Psychopharmacol Bull       Date:  2018-02-05

3.  Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.

Authors:  Xinyu Zhou; Teng Teng; Yuqing Zhang; Cinzia Del Giovane; Toshi A Furukawa; John R Weisz; Xuemei Li; Pim Cuijpers; David Coghill; Yajie Xiang; Sarah E Hetrick; Stefan Leucht; Mengchang Qin; Jürgen Barth; Arun V Ravindran; Lining Yang; John Curry; Li Fan; Susan G Silva; Andrea Cipriani; Peng Xie
Journal:  Lancet Psychiatry       Date:  2020-07       Impact factor: 27.083

4.  ADHD Medication and Substance-Related Problems.

Authors:  Patrick D Quinn; Zheng Chang; Kwan Hur; Robert D Gibbons; Benjamin B Lahey; Martin E Rickert; Arvid Sjölander; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  Am J Psychiatry       Date:  2017-06-29       Impact factor: 18.112

5.  Risk of Suicidal Behaviors and Antidepressant Exposure Among Children and Adolescents: A Meta-Analysis of Observational Studies.

Authors:  Kuan Li; Guibao Zhou; Yan Xiao; Jiayu Gu; Qiuling Chen; Shouxia Xie; Junyan Wu
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

6.  Variation in the 12-Month Treatment Trajectories of Children and Adolescents After a Diagnosis of Depression.

Authors:  Nina R Joyce; Megan S Schuler; Scott E Hadland; Laura A Hatfield
Journal:  JAMA Pediatr       Date:  2018-01-01       Impact factor: 16.193

7.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.